FDA Backs Greater Cancer-Prevention Claims for Gardasil

The human papillomavirus vaccine Gardasil has been approved for a new claim: preventing vaginal and vulvar cancer caused by HPV types 16 and 18, in females aged 9-26, the Food and Drug Administration announced last month.